Literature DB >> 12064763

Some thoughts on outcomes research, quality improvement, and performance measurement.

Edward B Perrin1.   

Abstract

Outcomes research, quality improvement, and performance measurement are important activities in the cancer research community. They are, indeed, closely related activities because indicators of quality and performance can logically be regarded as the outcomes of interest in outcomes research. Considerable progress has been made in the past decade in broadening the definition and strengthening the measurement of the important outcomes of health care in general, and cancer care specifically. The real value of studying outcomes, according to the Donabedian paradigm, lies in understanding their relation to the structure and processes (eg, the health care) that have produced them, because it is these latter factors which we can control. Therefore, the methods that we have available to us by which we can infer this relation of causality become very important. Because the systems that we study in health care research are usually complex, we will need to invest more of our resources in the future in the development of methods of inference beyond what we have available now if we are to realize the full potential of health outcomes research. This presents a unique opportunity for leadership by the cancer outcomes research program.

Entities:  

Mesh:

Year:  2002        PMID: 12064763     DOI: 10.1097/00005650-200206001-00013

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  2 in total

Review 1.  Primary care practice-based research networks: working at the interface between research and quality improvement.

Authors:  James W Mold; Kevin A Peterson
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

Review 2.  Assisting allied health in performance evaluation: a systematic review.

Authors:  Lucylynn Lizarondo; Karen Grimmer; Saravana Kumar
Journal:  BMC Health Serv Res       Date:  2014-11-14       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.